blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3402534

EP3402534 - CELLULAR BLEND FOR THE REGENERATION OF CHONDROCYTES OR CARTILAGE TYPE CELLS [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  04.06.2021
Database last updated on 24.07.2024
FormerRequest for examination was made
Status updated on  19.10.2018
FormerThe international publication has been made
Status updated on  21.07.2017
Most recent event   Tooltip15.12.2023New entry: Renewal fee paid 
Applicant(s)For all designated states
Spinalcyte, LLC
17006 Evergreen Elm Way
Houston, TX 77059 / US
[2018/47]
Inventor(s)01 / O'HEERON, Pete
17006 Evergreen Elm Way
Houston, TX 77059 / US
 [2018/52]
Former [2018/47]01 / O'HEERON, Pete
17300 Ei Camino Real
Suite 110
Houston, TX 77058 / US
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[N/P]
Former [2018/47]J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Application number, filing date17739050.713.01.2017
[2018/47]
WO2017US13449
Priority number, dateUS201662278635P14.01.2016         Original published format: US 201662278635 P
US201662413587P27.10.2016         Original published format: US 201662413587 P
[2018/47]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017123951
Date:20.07.2017
Language:EN
[2017/29]
Type: A1 Application with search report 
No.:EP3402534
Date:21.11.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 20.07.2017 takes the place of the publication of the European patent application.
[2018/47]
Search report(s)International search report - published on:US20.07.2017
(Supplementary) European search report - dispatched on:EP16.08.2019
ClassificationIPC:A61K48/00, A61K35/16, A61K35/19, A61K35/32, A61K35/33, A61K35/35, C12N5/077
[2019/38]
CPC:
C12N5/0655 (EP,US); A61K35/32 (US); A61K35/16 (US);
A61K35/19 (US); A61K35/33 (US); A61K35/35 (US);
A61P19/00 (EP); C12N2501/60 (EP,US) (-)
Former IPC [2018/47]A61K48/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/47]
Extension statesBA12.07.2018
ME12.07.2018
TitleGerman:ZELLULÄRE MISCHUNG ZUR REGENERATION VON CHONDROZYTEN ODER KNORPELZELLEN[2018/47]
English:CELLULAR BLEND FOR THE REGENERATION OF CHONDROCYTES OR CARTILAGE TYPE CELLS[2018/47]
French:MÉLANGE CELLULAIRE DESTINÉ À LA RÉGÉNÉRATION DE CHONDROCYTES OU DE CELLULES DE TYPE CARTILAGINEUX[2018/47]
Entry into regional phase12.07.2018National basic fee paid 
12.07.2018Search fee paid 
12.07.2018Designation fee(s) paid 
12.07.2018Examination fee paid 
Examination proceduredeletedDate on which the examining division has become responsible
12.07.2018Examination requested  [2018/47]
01.04.2020Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
04.06.2020Amendment by applicant (claims and/or description)
08.06.2021Despatch of a communication from the examining division (Time limit: M04)
11.10.2021Reply to a communication from the examining division
23.11.2022Despatch of a communication from the examining division (Time limit: M06)
05.06.2023Reply to a communication from the examining division
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
04.06.2020Request for further processing filed
04.06.2020Full payment received (date of receipt of payment)
Request granted
16.06.2020Decision despatched
Fees paidRenewal fee
15.01.2019Renewal fee patent year 03
29.06.2020Renewal fee patent year 04
29.03.2021Renewal fee patent year 05
28.01.2022Renewal fee patent year 06
12.01.2023Renewal fee patent year 07
14.12.2023Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
31.01.202004   M06   Fee paid on   29.06.2020
31.01.202105   M06   Fee paid on   29.03.2021
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]US2007184033  (SEVRAIN LIONEL C [US], et al) [Y] 1-15 * [0013][0021],[0057], [0083], [0127];; examples 1-4 *;
 [Y]EP2034010  (OMRIX BIOPHARMACEUTICALS LTD [IL]) [Y] 1-15* Paragraphs [0033], [0051], [0055-57], [0063], [0068], [0073-83], [0087-90];; examples 1-3; claims 1-37 *;
 [X]WO2010088775  (UNIV HEALTH NETWORK [CA], et al) [X] 1-6,8-12,15 * Paragraphs [0002], [0004], [0006], [0014-18], [0024], [0041], [00217], [00238], [00267];; examples 4, 5; claims 1-50 *;
 [Y]WO2013070880  (SPINALCYTE LLC [US], et al) [Y] 1-15 * Broad outline paragraphs [0011], [0014-24], Details: pararaphs [0028-40], [0043], [0046];; example 1 *;
 [Y]WO2014204806  (SPINALCYTE LLC [US]) [Y] 1-15 * Paragraphs [0013], [0014], [0018], [0028], [0043-44], [0047], [0078];; examples 1-2 *;
 [XI]WO2015035395  (FIGENE LLC [US]) [X] 1-3,6-12,15 * Summary of invention: paragraphs [0009] - [0016] Detailed description: paragraphs [0022],[0032],[0034-35], [0037-38], (sox9 protein delivery by cells), [0040-41];; examples 1-2 * * Genes used in therapy: paragraphs [0044] - [0055],;; claims 1-14 * [I] 4,5,13,14
International search[A]WO2014026012  (ADVANCED MED TECH [US]) [A] 1* ; abstract *;
 [X]WO2015035395  (FIGENE LLC [US]) [X] 1-3, 19-21, 23-26 and 28- 30 * ; abstract; para [0013], [0016], [0032], [0035], [0040], [0043], [0045], [0046], [0048], [0050], [0061], [0142], claim 2, claim 4 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.